Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
Intervalo de año de publicación
1.
Hautarzt ; 64(2): 114-6, 2013 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-23223901

RESUMEN

A 63-year old woman presented with dry necrotic areas on the distal and medial phalanges of her right index and middle finger caused by burns while smoking. Differential diagnostic considerations included occlusive arterial disease, vasculitis, endangiitis obliterans, peripheral embolisms and exposure to chemicals. The patient had the habit of smoking her cigarettes until the last possible drag, putting her skin in direct contact with the burning tobacco.


Asunto(s)
Quemaduras/patología , Traumatismos de los Dedos/patología , Piel/lesiones , Piel/patología , Fumar/efectos adversos , Productos de Tabaco/efectos adversos , Diagnóstico Diferencial , Femenino , Humanos , Persona de Mediana Edad , Necrosis
2.
Hautarzt ; 63(11): 885-98, 2012 Nov.
Artículo en Alemán | MEDLINE | ID: mdl-23114509

RESUMEN

For decades dacarbazine was the standard in the therapy for metastatic melanoma even though response rates were low. In recent years multiple pharmacological approaches have led to new therapy options including immune modulators like anti-CTLA4 antibodies and kinase inhibitors of the MAPK signaling pathway that showed better response rates and increased overall survival. However, since immune modulators lead only in a small subgroup of patients to long-term responses and kinase inhibitors lose their function due to development of resistance after several months, continuation of clinical studies is strongly required. Classical chemotherapeutic drugs will remain a basic part of the therapy especially as combinations of different treatment options have to be focused on in order to achieve better long-term survival rates.


Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Antineoplásicos/uso terapéutico , Factores Inmunológicos/uso terapéutico , Melanoma/tratamiento farmacológico , Terapia Molecular Dirigida/tendencias , Neoplasias Cutáneas/tratamiento farmacológico , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA